News & Research

SUBSCRIBE TO OUR NEWSLETTER
November 14, 2022
/
CBS Sunday Morning
Using psychedelics to treat veterans' PTSD
Some suffering from Post-Traumatic Stress Disorder have had little relief from traditional anti-depressants; now, a recent FDA-approved trial using MDMA – a.k.a. ecstasy – has shown promising results.
Read more
November 5, 2022
/
TODAY
‘I’m better mentally now’: Veteran shares experience of MDMA treatment for PTSD
Jon Lubecky was desperate when he signed up for a clinical trial testing a new type of therapy for post-traumatic stress disorder, one that included the use of a psychedelic drug called MDMA, known on the street as “ecstasy” and “molly.” Tortured by memories from his tours in Iraq, the retired army sergeant had attempted suicide five times. Now he saw the possibility that he could get past those memories so that his son would have “a father instead of a folded flag.”
Read more
October 28, 2022
/
THE NEW YORK TIMES
Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
Jose Martinez, a former Army gunner whose right arm and both legs were blown off by a roadside bomb in Afghanistan, has a new calling: He’s become one of the most effective lobbyists in a campaign to legalize the therapeutic use of psychedelic drugs across the country.
Read more
June 11, 2021
/
press release
PRESS RELEASE: DC Based Plant Medicine Coalition Changes Name, Adds Former Congressmember and Others to Board
Read more
February 15, 2021
/
ROLLING STONE
Will the Federal Government Finally Embrace the Psychedelic Revolution?
From approving religious exemptions to budgeting for medical research, advocates are hopeful that Biden and a Democratic Congress could mean progress for psilocybin and other therapeutic psychedelics. Psychedelic reform isn’t exactly President Joe Biden’s top priority. But as his administration and the new congress gets underway, advocates are hopeful that the next four years will continue to bring policy changes that chip away at the federal prohibition of psilocybin, MDMA, and other psychedelics.
Read more
A Legal Overview of the Controlled Substances Act (CSA) for the 118th Congress
The Congressional Research Service’s updated brief discusses the current state of the CSA and how new legislation and ballot measures, like PMC founder Melissa Lavasani’s Decriminalize Nature DC movement, are renewing focus on the scheduling of certain substances, like marijuana and psilocybin.
Read more
SUBSCRIBE TO OUR NEWSLETTER
December 10, 2022
/
press release
Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
Jose Martinez, a former Army gunner whose right arm and both legs were blown off by a roadside bomb in Afghanistan, has a new calling: He’s become one of the most effective lobbyists in a campaign to legalize the therapeutic use of psychedelic drugs across the country.
Read more